Dysregulation of miR-31 and miR-375 expression is associated with clinical outcomes in oral carcinoma.
about
miRNAs Signature in Head and Neck Squamous Cell Carcinoma Metastasis: A Literature ReviewCurrent relevance of hypoxia in head and neck cancerBioinformatics analyses combined microarray identify the deregulated microRNAs in oral cancerComparison of the miRNA expression profiles in fresh frozen and formalin-fixed paraffin-embedded tonsillar tumorsMicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer.MicroRNA-375 Suppresses Extracellular Matrix Degradation and Invadopodial Activity in Head and Neck Squamous Cell CarcinomaDevelopment of a circulating miRNA assay to monitor tumor burden: From mouse to manmiR-486-3p, miR-139-5p, and miR-21 as Biomarkers for the Detection of Oral Tongue Squamous Cell Carcinoma.The diverse role of miR-31 in regulating cancer associated phenotypes.MiR-375/SLC7A11 axis regulates oral squamous cell carcinoma proliferation and invasion.MicroRNA-375 functions as a tumor suppressor in osteosarcoma by targeting PIK3CA.Upregulation of microRNA-375 is associated with poor prognosis in pediatric acute myeloid leukemia.A Looking-Glass of Non-coding RNAs in oral cancer.MicroRNAs expression profile in solid and unicystic ameloblastomas.MicroRNA-196a-5p is a potential prognostic marker of delayed lymph node metastasis in early-stage tongue squamous cell carcinoma.Current Insights into Oral Cancer Epigenetics.MicroRNA expression as predictor of local recurrence risk in oral squamous cell carcinoma.The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.MicroRNA meta-signature of oral cancer: evidence from a meta-analysis.Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma.
P2860
Q26747138-78675E9F-1C16-4994-844A-C893EC718F94Q28074577-7E5E88E1-C525-4681-B11F-93A6A0A1ABC0Q33778249-2ED0DA83-BDAE-41BA-AFC1-643A549A56C9Q33828907-9EE80D43-22AA-416B-9919-1AF78C6CB306Q35781512-E5F15BC0-02A9-4A8A-BB25-4CA0D8E8D1CBQ36235848-E69CD493-A5F0-4AAF-85B5-F595F9C31181Q36571424-DCAB875F-8955-4325-B22E-ED9AA9A26198Q37577131-301D2013-9E6B-4B4A-86E6-A3E6EDBF15F0Q38133768-A355A11D-BBCD-44B5-9DCA-EAB9F9D8D4F1Q38699922-9E875474-696D-4BC5-90AD-9F658A66F5CBQ38868180-D508B259-31D6-4E49-95C9-D5D25ED2F1A2Q46679788-6450707D-4AFB-4F86-ABD6-8F10C26A3074Q47800026-0776C97A-29C0-4423-BCFF-F62056710400Q48154030-9CF08EB8-6F7E-4EC6-804B-AAC968DE68D1Q49690867-3C2D003E-ED5B-4BD9-B5DA-5F345AB34FC8Q52679071-266B0A90-5A60-4DDA-A1AE-4583D21B77D8Q53226065-F6E333C4-B42A-4F14-BC3F-702D48456870Q53592908-DC8F03D3-6C66-46B3-A4B0-2F9CA85DD041Q55365878-8857BB0F-F372-47CA-BDDA-D4F8A2D55A07Q55418427-D0B05B6B-3E5E-4509-BE25-9BAE935E717E
P2860
Dysregulation of miR-31 and miR-375 expression is associated with clinical outcomes in oral carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Dysregulation of miR-31 and mi ...... al outcomes in oral carcinoma.
@en
Dysregulation of miR-31 and mi ...... al outcomes in oral carcinoma.
@nl
type
label
Dysregulation of miR-31 and mi ...... al outcomes in oral carcinoma.
@en
Dysregulation of miR-31 and mi ...... al outcomes in oral carcinoma.
@nl
prefLabel
Dysregulation of miR-31 and mi ...... al outcomes in oral carcinoma.
@en
Dysregulation of miR-31 and mi ...... al outcomes in oral carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Dysregulation of miR-31 and mi ...... cal outcomes in oral carcinoma
@en
P2093
L P Karen Ng
M Jamaludin
M T Abraham
S C Cheong
T G Kallarakkal
V K Vincent-Chong
Z A Abdul Rahman
P2860
P304
P356
10.1111/ODI.12118
P50
P577
2013-05-07T00:00:00Z